Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05561595 · ClinicalTrials.gov registry record · NA

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

A NA study of Obesity and Cancer, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
195
Enrollment target
1
Study location

NCT05561595 is a NA study of Obesity and Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 195 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05561595, a NA study of Obesity and Cancer, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
195 participants
Enrollment target
1
Study location

Study Summary

Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.

Interventions

  • BEHAVIORAL Healing HEARTS
  • BEHAVIORAL Peer Support

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2024-10-03
Est. Completion 2027-03-31
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT05561595

The ClinicalTrials.gov registry entry for NCT05561595 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Healing HEARTS is the first listed.

NCT05561595 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05561595 about?

NCT05561595 is a clinical study titled "Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma". Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and...

What is the current status of trial NCT05561595?

This trial is currently recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2024-10-03. Estimated completion is 2027-03-31.

What conditions does trial NCT05561595 study?

This clinical trial studies the following conditions: Obesity, Cancer, Diabetes, HIV, Chronic Pain.

What interventions are being tested in trial NCT05561595?

The interventions under investigation include: Healing HEARTS (BEHAVIORAL), Peer Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT05561595?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05561595 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.